Skip to main content
Top
Published in: Calcified Tissue International 2/2013

01-08-2013 | Original Research

Association of n-3 Polyunsaturated Fatty Acid Intake with Bone Mineral Density in Postmenopausal Women

Authors: Kiyoko Nawata, Mika Yamauchi, Shin Takaoka, Toru Yamaguchi, Toshitsugu Sugimoto

Published in: Calcified Tissue International | Issue 2/2013

Login to get access

Abstract

n-3 Polyunsaturated fatty acids (n-3 fatty acids) have been shown to have a beneficial effect on bone in animal studies, although little is known about their role in bone metabolism in humans. We investigated the association between bone mineral density (BMD) and daily n-3 fatty acid intake. This cross-sectional, community-based, epidemiologic study was conducted among 205 healthy postmenopausal women (mean age 63.5 years, range 46–79). We examined BMD, serum N-terminal propeptide of type I collagen (PINP), urinary type-I collagen cross-linked-N-telopeptide (uNTX), total cholesterol, triglycerides, and high-density lipoprotein cholesterol. Nutrient intake was calculated using a food-frequency questionnaire. BMD was measured at the lumbar spine and femoral neck by dual-energy X-ray absorptiometry. Simple regression analysis showed that intake of neither n-3 fatty acid nor n-6 fatty acid was associated with age or lipid metabolism indices. However, simple regression analysis showed that n-3 fatty acid intake was positively associated with both lumbar spine BMD and femoral neck BMD. n-6 fatty acid intake was positively associated with femoral neck BMD but not lumbar spine BMD. Multiple regression analysis showed that n-3 fatty acid intake was positively associated with lumbar spine BMD after adjustment for age, BMI, duration of menopausal state, grip strength, PINP, uNTX, and intakes of calcium, vitamin D, vitamin K, and n-6 fatty acid. In conclusion, n-3 fatty acid intake was positively associated with lumbar spine BMD independent of bone resorption and serum levels of cholesterol and triglycerides in postmenopausal women.
Literature
2.
go back to reference Poulsen RC, Moughan PJ, Kruger MC (2007) Long-chain polyunsaturated fatty acids and the regulation of bone metabolism. Exp Biol Med 232:1275–1288CrossRef Poulsen RC, Moughan PJ, Kruger MC (2007) Long-chain polyunsaturated fatty acids and the regulation of bone metabolism. Exp Biol Med 232:1275–1288CrossRef
3.
go back to reference Watkins BA, Li Y, Lippman HE, Feng S (2003) Modulatory effect of omega-3 polyunsaturated fatty acids on osteoblast function and bone metabolism. Prostaglandins Leukot Essent Fatty Acids 68:387–398PubMedCrossRef Watkins BA, Li Y, Lippman HE, Feng S (2003) Modulatory effect of omega-3 polyunsaturated fatty acids on osteoblast function and bone metabolism. Prostaglandins Leukot Essent Fatty Acids 68:387–398PubMedCrossRef
4.
go back to reference Rahman MM, Bhattacharya A, Fernandes G (2008) Docosahexaenoic acid is more potent inhibitor of osteoclast differentiation in RAW 264.7 cells than eicosapentaenoic acid. J Cell Physiol 214:201–209PubMedCrossRef Rahman MM, Bhattacharya A, Fernandes G (2008) Docosahexaenoic acid is more potent inhibitor of osteoclast differentiation in RAW 264.7 cells than eicosapentaenoic acid. J Cell Physiol 214:201–209PubMedCrossRef
5.
go back to reference Shen CL, Yeh JK, Rasty J, Li Y, Watkins BA (2006) Protective effect of dietary long-chain n-3 polyunsaturated fatty acids on bone loss in gonad-intact middle-aged male rats. Br J Nutr 95:462–468PubMedCrossRef Shen CL, Yeh JK, Rasty J, Li Y, Watkins BA (2006) Protective effect of dietary long-chain n-3 polyunsaturated fatty acids on bone loss in gonad-intact middle-aged male rats. Br J Nutr 95:462–468PubMedCrossRef
6.
go back to reference Tarlton JF, Wilkins LJ, Toscano MJ, Avery NC, Knott L (2013) Reduced bone breakage and increased bone strength in free range laying hens fed omega-3 polyunsaturated fatty acid supplemented diets. Bone 52:578–586PubMedCrossRef Tarlton JF, Wilkins LJ, Toscano MJ, Avery NC, Knott L (2013) Reduced bone breakage and increased bone strength in free range laying hens fed omega-3 polyunsaturated fatty acid supplemented diets. Bone 52:578–586PubMedCrossRef
7.
go back to reference Sun D, Krishnan A, Zaman K, Lawrence R, Bhattacharya A, Fernandes G (2003) Dietary n-3 fatty acids decrease osteoclastogenesis and loss of bone mass in ovariectomized mice. J Bone Miner Res 18:1206–1216PubMedCrossRef Sun D, Krishnan A, Zaman K, Lawrence R, Bhattacharya A, Fernandes G (2003) Dietary n-3 fatty acids decrease osteoclastogenesis and loss of bone mass in ovariectomized mice. J Bone Miner Res 18:1206–1216PubMedCrossRef
8.
go back to reference Bonnet N, Ferrari SL (2011) Effects of long-term supplementation with omega-3 fatty acids on longitudinal changes in bone mass and microstructure in mice. J Nutr Biochem 22:665–672PubMedCrossRef Bonnet N, Ferrari SL (2011) Effects of long-term supplementation with omega-3 fatty acids on longitudinal changes in bone mass and microstructure in mice. J Nutr Biochem 22:665–672PubMedCrossRef
9.
go back to reference Lau BY, Ward WE, Kang JX, Ma DW (2009) Femur EPA and DHA are correlated with femur biomechanical strength in young fat-1 mice. J Nutr Biochem 20:453–461PubMedCrossRef Lau BY, Ward WE, Kang JX, Ma DW (2009) Femur EPA and DHA are correlated with femur biomechanical strength in young fat-1 mice. J Nutr Biochem 20:453–461PubMedCrossRef
10.
go back to reference Griel AE, Kris-Etherton PM, Hilpert KF, Zhao G, West SG, Corwin RL (2007) An increase in dietary n-3 fatty acids decreases a marker of bone resorption in humans. Nutr J 6:2PubMedCrossRef Griel AE, Kris-Etherton PM, Hilpert KF, Zhao G, West SG, Corwin RL (2007) An increase in dietary n-3 fatty acids decreases a marker of bone resorption in humans. Nutr J 6:2PubMedCrossRef
11.
go back to reference Martin-Bautista E, Munoz-Torres M, Fonolla J, Quesada M, Poyatos A, Lopez-Huertas E (2010) Improvement of bone formation biomarkers after 1-year consumption with milk fortified with eicosapentaenoic acid, docosahexaenoic acid, oleic acid, and selected vitamins. Nutr Res 30:320–326PubMedCrossRef Martin-Bautista E, Munoz-Torres M, Fonolla J, Quesada M, Poyatos A, Lopez-Huertas E (2010) Improvement of bone formation biomarkers after 1-year consumption with milk fortified with eicosapentaenoic acid, docosahexaenoic acid, oleic acid, and selected vitamins. Nutr Res 30:320–326PubMedCrossRef
12.
go back to reference Rousseau JH, Kleppinger A, Kenny AM (2009) Self-reported dietary intake of omega-3 fatty acids and association with bone and lower extremity function. J Am Geriatr Soc 57:1781–1788PubMedCrossRef Rousseau JH, Kleppinger A, Kenny AM (2009) Self-reported dietary intake of omega-3 fatty acids and association with bone and lower extremity function. J Am Geriatr Soc 57:1781–1788PubMedCrossRef
13.
go back to reference Virtanen JK, Mozaffarian D, Cauley JA, Mukamal KJ, Robbins J, Siscovick DS (2010) Fish consumption, bone mineral density, and risk of hip fracture among older adults: the cardiovascular health study. J Bone Miner Res 25:1972–1979PubMedCrossRef Virtanen JK, Mozaffarian D, Cauley JA, Mukamal KJ, Robbins J, Siscovick DS (2010) Fish consumption, bone mineral density, and risk of hip fracture among older adults: the cardiovascular health study. J Bone Miner Res 25:1972–1979PubMedCrossRef
14.
go back to reference Weiss LA, Barrett-Connor E, von Muhlen D (2005) Ratio of n-6 to n-3 fatty acids and bone mineral density in older adults: the Rancho Bernardo Study. Am J Clin Nutr 81:934–938PubMed Weiss LA, Barrett-Connor E, von Muhlen D (2005) Ratio of n-6 to n-3 fatty acids and bone mineral density in older adults: the Rancho Bernardo Study. Am J Clin Nutr 81:934–938PubMed
15.
go back to reference Dodin S, Lemay A, Jacques H, Legare F, Forest JC, Masse B (2005) The effects of flaxseed dietary supplement on lipid profile, bone mineral density, and symptoms in menopausal women: a randomized, double-blind, wheat germ placebo-controlled clinical trial. J Clin Endocrinol Metab 90:1390–1397PubMedCrossRef Dodin S, Lemay A, Jacques H, Legare F, Forest JC, Masse B (2005) The effects of flaxseed dietary supplement on lipid profile, bone mineral density, and symptoms in menopausal women: a randomized, double-blind, wheat germ placebo-controlled clinical trial. J Clin Endocrinol Metab 90:1390–1397PubMedCrossRef
16.
go back to reference Farina EK, Kiel DP, Roubenoff R, Schaefer EJ, Cupples LA, Tucker KL (2011) Protective effects of fish intake and interactive effects of long-chain polyunsaturated fatty acid intakes on hip bone mineral density in older adults: the Framingham osteoporosis Study. Am J Clin Nutr 93:1142–1151PubMedCrossRef Farina EK, Kiel DP, Roubenoff R, Schaefer EJ, Cupples LA, Tucker KL (2011) Protective effects of fish intake and interactive effects of long-chain polyunsaturated fatty acid intakes on hip bone mineral density in older adults: the Framingham osteoporosis Study. Am J Clin Nutr 93:1142–1151PubMedCrossRef
17.
go back to reference Otsuka R, Kato Y, Imai T, Ando F, Shimokata H (2013) Higher serum EPA or DHA, and lower ARA compositions with age independent fatty acid intake in Japanese aged 40 to 79. Lipids. doi:10.1007/s11745-013-3763-9 Otsuka R, Kato Y, Imai T, Ando F, Shimokata H (2013) Higher serum EPA or DHA, and lower ARA compositions with age independent fatty acid intake in Japanese aged 40 to 79. Lipids. doi:10.​1007/​s11745-013-3763-9
18.
go back to reference Garnero P, Vergnaud P, Hoyle N (2008) Evaluation of a fully automated serum assay for total N-terminal propeptide of type I collagen in postmenopausal osteoporosis. Clin Chem 54:188–196PubMedCrossRef Garnero P, Vergnaud P, Hoyle N (2008) Evaluation of a fully automated serum assay for total N-terminal propeptide of type I collagen in postmenopausal osteoporosis. Clin Chem 54:188–196PubMedCrossRef
19.
go back to reference Takahashi KYY, Sekimoto T, Kunii D, Komatsu T, Yamamoto S (2001) Validation of food frequency questionnaire based on food groups for estimating individual nutrient intake. Jpn J Nutr 59:221–232CrossRef Takahashi KYY, Sekimoto T, Kunii D, Komatsu T, Yamamoto S (2001) Validation of food frequency questionnaire based on food groups for estimating individual nutrient intake. Jpn J Nutr 59:221–232CrossRef
20.
go back to reference Caughey GE, Mantzioris E, Gibson RA, Cleland LG, James MJ (1996) The effect on human tumor necrosis factor alpha and interleukin 1 beta production of diets enriched in n-3 fatty acids from vegetable oil or fish oil. Am J Clin Nutr 63:116–122PubMed Caughey GE, Mantzioris E, Gibson RA, Cleland LG, James MJ (1996) The effect on human tumor necrosis factor alpha and interleukin 1 beta production of diets enriched in n-3 fatty acids from vegetable oil or fish oil. Am J Clin Nutr 63:116–122PubMed
21.
go back to reference Cleland LG, James MJ, Neumann MA, D’Angelo M, Gibson RA (1992) Linoleate inhibits EPA incorporation from dietary fish-oil supplements in human subjects. Am J Clin Nutr 55:395–399PubMed Cleland LG, James MJ, Neumann MA, D’Angelo M, Gibson RA (1992) Linoleate inhibits EPA incorporation from dietary fish-oil supplements in human subjects. Am J Clin Nutr 55:395–399PubMed
22.
go back to reference Meydani SN, Lichtenstein AH, Cornwall S, Meydani M, Goldin BR, Rasmussen H, Dinarello CA, Schaefer EJ (1993) Immunologic effects of national cholesterol education panel step-2 diets with and without fish-derived N-3 fatty acid enrichment. J Clin Invest 92:105–113PubMedCrossRef Meydani SN, Lichtenstein AH, Cornwall S, Meydani M, Goldin BR, Rasmussen H, Dinarello CA, Schaefer EJ (1993) Immunologic effects of national cholesterol education panel step-2 diets with and without fish-derived N-3 fatty acid enrichment. J Clin Invest 92:105–113PubMedCrossRef
23.
go back to reference Salari P, Rezaie A, Larijani B, Abdollahi M (2008) A systematic review of the impact of n-3 fatty acids in bone health and osteoporosis. Med Sci Monit 14:RA37–RA44PubMed Salari P, Rezaie A, Larijani B, Abdollahi M (2008) A systematic review of the impact of n-3 fatty acids in bone health and osteoporosis. Med Sci Monit 14:RA37–RA44PubMed
24.
go back to reference Bhattacharya A, Rahman M, Banu J, Lawrence RA, McGuff HS, Garrett IR, Fischbach M, Fernandes G (2005) Inhibition of osteoporosis in autoimmune disease prone MRL/Mpj-Fas(lpr) mice by N-3 fatty acids. J Am Coll Nutr 24:200–209PubMedCrossRef Bhattacharya A, Rahman M, Banu J, Lawrence RA, McGuff HS, Garrett IR, Fischbach M, Fernandes G (2005) Inhibition of osteoporosis in autoimmune disease prone MRL/Mpj-Fas(lpr) mice by N-3 fatty acids. J Am Coll Nutr 24:200–209PubMedCrossRef
25.
go back to reference Virtanen JK, Mozaffarian D, Willett WC, Feskanich D (2012) Dietary intake of polyunsaturated fatty acids and risk of hip fracture in men and women. Osteoporos Int 23:2615–2624PubMedCrossRef Virtanen JK, Mozaffarian D, Willett WC, Feskanich D (2012) Dietary intake of polyunsaturated fatty acids and risk of hip fracture in men and women. Osteoporos Int 23:2615–2624PubMedCrossRef
26.
go back to reference Farina EK, Kiel DP, Roubenoff R, Schaefer EJ, Cupples LA, Tucker KL (2011) Dietary intakes of arachidonic acid and alpha-linolenic acid are associated with reduced risk of hip fracture in older adults. J Nutr 141:1146–1153PubMedCrossRef Farina EK, Kiel DP, Roubenoff R, Schaefer EJ, Cupples LA, Tucker KL (2011) Dietary intakes of arachidonic acid and alpha-linolenic acid are associated with reduced risk of hip fracture in older adults. J Nutr 141:1146–1153PubMedCrossRef
27.
go back to reference Hogstrom M, Nordstrom P, Nordstrom A (2007) n-3 Fatty acids are positively associated with peak bone mineral density and bone accrual in healthy men: the NO2 Study. Am J Clin Nutr 85:803–807PubMed Hogstrom M, Nordstrom P, Nordstrom A (2007) n-3 Fatty acids are positively associated with peak bone mineral density and bone accrual in healthy men: the NO2 Study. Am J Clin Nutr 85:803–807PubMed
28.
go back to reference Kruger MC, Coetzer H, de Winter R, Gericke G, van Papendorp DH (1998) Calcium, gamma-linolenic acid and eicosapentaenoic acid supplementation in senile osteoporosis. Aging (Milano) 10:385–394 Kruger MC, Coetzer H, de Winter R, Gericke G, van Papendorp DH (1998) Calcium, gamma-linolenic acid and eicosapentaenoic acid supplementation in senile osteoporosis. Aging (Milano) 10:385–394
29.
go back to reference Bassey EJ, Littlewood JJ, Rothwell MC, Pye DW (2000) Lack of effect of supplementation with essential fatty acids on bone mineral density in healthy pre- and postmenopausal women: two randomized controlled trials of Efacal v. calcium alone. Br J Nutr 83:629–635PubMedCrossRef Bassey EJ, Littlewood JJ, Rothwell MC, Pye DW (2000) Lack of effect of supplementation with essential fatty acids on bone mineral density in healthy pre- and postmenopausal women: two randomized controlled trials of Efacal v. calcium alone. Br J Nutr 83:629–635PubMedCrossRef
30.
go back to reference Finnegan YE, Minihane AM, Leigh-Firbank EC, Kew S, Meijer GW, Muggli R, Calder PC, Williams CM (2003) Plant- and marine-derived n-3 polyunsaturated fatty acids have differential effects on fasting and postprandial blood lipid concentrations and on the susceptibility of LDL to oxidative modification in moderately hyperlipidemic subjects. Am J Clin Nutr 77:783–795 Finnegan YE, Minihane AM, Leigh-Firbank EC, Kew S, Meijer GW, Muggli R, Calder PC, Williams CM (2003) Plant- and marine-derived n-3 polyunsaturated fatty acids have differential effects on fasting and postprandial blood lipid concentrations and on the susceptibility of LDL to oxidative modification in moderately hyperlipidemic subjects. Am J Clin Nutr 77:783–795
31.
go back to reference Harris WS (1997) n-3 Fatty acids and serum lipoproteins: human studies. Am J Clin Nutr 65:1645S–1654SPubMed Harris WS (1997) n-3 Fatty acids and serum lipoproteins: human studies. Am J Clin Nutr 65:1645S–1654SPubMed
Metadata
Title
Association of n-3 Polyunsaturated Fatty Acid Intake with Bone Mineral Density in Postmenopausal Women
Authors
Kiyoko Nawata
Mika Yamauchi
Shin Takaoka
Toru Yamaguchi
Toshitsugu Sugimoto
Publication date
01-08-2013
Publisher
Springer US
Published in
Calcified Tissue International / Issue 2/2013
Print ISSN: 0171-967X
Electronic ISSN: 1432-0827
DOI
https://doi.org/10.1007/s00223-013-9743-5

Other articles of this Issue 2/2013

Calcified Tissue International 2/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.